Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
33.62
+0.74 (2.25%)
At close: Jun 12, 2026, 4:00 PM EDT
33.75
+0.13 (0.39%)
After-hours: Jun 12, 2026, 7:48 PM EDT
Immunovant Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $66 | Buy | Maintains | $66 | +96.31% | May 29, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $35 → $47 | Buy | Maintains | $35 → $47 | +39.80% | May 26, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $44 → $62 | Buy | Maintains | $44 → $62 | +84.41% | May 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +18.98% | May 26, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $49 | Buy | Maintains | $49 | +45.75% | May 25, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $23 → $30 | Hold | Maintains | $23 → $30 | -10.77% | May 21, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $42 → $45 | Buy | Reiterates | $42 → $45 | +33.85% | May 21, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $32 → $43 | Buy | Maintains | $32 → $43 | +27.90% | May 21, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.